![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Axio Biosolutions Gets FDA 510(k) Clearance for Hemostatic Axiostat Patch
Axio Biosolutions Gets FDA 510(k) Clearance for Hemostatic Axiostat Patch
India-based Axio Biosolutions has received FDA 510(k) clearance for its hemostatic Axiostat patch.
The patch, which previously earned CE mark certification, is for controlling moderate-to-severe bleeding in vascular procedures and at the sites of surgical debridement and punctures.
The Axiostat patch has bioadhesive properties that provide a strong mechanical barrier at the site of an injury, keeping out bacteria and reducing recovery time.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct